Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 28, 2020

SELL
$55.23 - $79.93 $46,061 - $66,661
-834 Closed
0 $0
Q4 2019

Jan 24, 2020

BUY
$25.43 - $36.67 $3,992 - $5,757
157 Added 23.19%
834 $30,000
Q3 2019

Oct 15, 2019

BUY
$23.0 - $27.97 $11,500 - $13,985
500 Added 282.49%
677 $18,000
Q2 2019

Jul 10, 2019

BUY
$22.81 - $28.48 $4,037 - $5,040
177 New
177 $4,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.